Assessing the impact of generative AI on medicinal chemistry

Mastering the game of Go with deep neural networks and tree search

Silver, D., Huang, A., Maddison, C. J., Guez, A., Sifre, L., van den Driessche, G., Schrittwieser, J., Antonoglou, I., Panneershelvam, V., Lanctot, M., et al. (2016) · Nature · doi:10.1038/nature16961 · Cited by 15,612 · see citing works

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · see citing works

Applications of machine learning in drug discovery and development

Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules

Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106 · see citing works

Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.

Gómez‐Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera‐Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru‐Guzik, A. (2018) · Cambridge University Engineering Department Publications Database · doi:10.17863/cam.34134 · Cited by 1,813 · see citing works

Deep learning enables rapid identification of potent DDR1 kinase inhibitors

Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573 · see citing works

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537 · see citing works

Computer-based de novo design of drug-like molecules

Schneider, G., & Fechner, U. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1799 · Cited by 956 · see citing works

GuacaMol: Benchmarking Models for de Novo Molecular Design

Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895 · see citing works

druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico

Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587 · see citing works

<i>De Novo</i> Design of Bioactive Small Molecules by Artificial Intelligence

Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373 · see citing works

Adversarial Threshold Neural Computer for Molecular de Novo Design

Lane, E., Asadulaev, A., Vanhaelen, Q., Ivanenkov, Y. A., Aladinskaya, A. V., Aliper, A., & Zhavoronkov, A. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01137 · Cited by 219 · see citing works

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies

Tan, F. H., Putoczki, T. L., Stylli, S. S., & Luwor, R. B. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s189391 · Cited by 206 · see citing works

Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors

Gao, M., Duan, L., Luo, J., Zhang, L., Lu, X., Zhang, Y., Zhang, Z., Tu, Z., Xu, Y., Ren, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301824k · Cited by 168 · see citing works

Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors

Canning, P., Tan, L., Chu, K., Lee, S. W., Gray, N. S., & Bullock, A. N. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.04.014 · Cited by 103 · see citing works

Drug Guru: A computer software program for drug design using medicinal chemistry rules

Stewart, K. D., Shiroda, M., & James, C. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.024 · Cited by 103 · see citing works

Autonomous Molecular Design: Then and Now

Dimitrov, T., Kreisbeck, C., Becker, J. S., Aspuru-Guzik, A., & Saikin, S. K. (2019) · ACS Applied Materials &amp; Interfaces · doi:10.1021/acsami.9b01226 · Cited by 103 · see citing works

Deep Generative Models for Molecular Science

Jørgensen, P. B., Schmidt, M. N., & Winther, O. (2018) · Molecular Informatics · doi:10.1002/minf.201700133 · Cited by 86 · see citing works

The scaffold hopping potential of pharmacophores

Heßler, G., & Baringhaus, K. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.09.001 · Cited by 72 · see citing works

Generative Models for Artificially‐intelligent Molecular Design

Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201880131 · Cited by 37 · see citing works

A ring‐bracing approach to computer‐assisted ligand design

Leach, A. R., & Lewis, R. A. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150213 · Cited by 16 · see citing works

Computational Medicinal Chemistry

Ståhl, M., & Bajorath, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1013055 · Cited by 10 · see citing works

Generative artificial intelligence

Banh, L., & Strobel, G. (2023) · Electronic Markets · doi:10.1007/s12525-023-00680-1 · Cited by 722 · see citing works

Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429 · see citing works

Applications of Deep Learning in Molecule Generation and Molecular Property Prediction

Walters, W. P., & Barzilay, R. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00699 · Cited by 393 · see citing works

Advancements in Generative AI: A Comprehensive Review of GANs, GPT, Autoencoders, Diffusion Model, and Transformers

Bengesi, S., El-Sayed, H., Sarker, M. K., Houkpati, Y., Irungu, J., & Oladunni, T. (2023) · IEEE Access · doi:10.1109/access.2024.3397775 · Cited by 286 · see citing works

Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis

Niazi, S. K., & Mariam, Z. (2023) · Pharmaceuticals · doi:10.3390/ph17010022 · Cited by 361 · see citing works

Generative models for molecular discovery: Recent advances and challenges

Bilodeau, C., Jin, W., Jaakkola, T., Barzilay, R., & Jensen, K. F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1608 · Cited by 333 · see citing works

AI in drug discovery and its clinical relevance

Qureshi, R., Irfan, M., Gondal, T. M., Khan, S., Wu, J., Hadi, M. U., Heymach, J., Le, X., Yan, H., & Alam, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17575 · Cited by 319 · see citing works

De novo molecular design and generative models

Meyers, J., Fabian, B., & Brown, N. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.019 · Cited by 300 · see citing works

BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data

Liu, T., Hwang, L., Burley, S. K., Nitsche, C. I., Southan, C., Walters, W. P., & Gilson, M. K. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1075 · Cited by 246 · see citing works

Generative Models for De Novo Drug Design

Tong, X., Liu, X., Tan, X., Li, X., Jiang, J., Xiong, Z., Xu, T., Jiang, H., Qiao, N., & Zheng, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00927 · Cited by 242 · see citing works

Artificial Intelligence for Drug Discovery: Are We There Yet?

Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works

Advanced machine-learning techniques in drug discovery

Elbadawi, M., Gaisford, S., & Basit, A. W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.003 · Cited by 229 · see citing works

Artificial intelligence in drug discovery: applications and techniques

Deng, J., Yang, Z., Ojima, I., Samaras, D., & Wang, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab430 · Cited by 236 · see citing works

Natural product drug discovery in the artificial intelligence era

Saldívar‐González, F. I., Aldas-Bulos, V. D., Medina‐Franco, J. L., & Plisson, F. (2021) · Chemical Science · doi:10.1039/d1sc04471k · Cited by 224 · see citing works

Learning Molecular Representations for Medicinal Chemistry

Chuang, K. V., Gunsalus, L. M., & Keiser, M. J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00385 · Cited by 227 · see citing works

A systematic study of key elements underlying molecular property prediction

Deng, J., Yang, Z., Wang, H., Ojima, I., Samaras, D., & Wang, F. (2023) · Nature Communications · doi:10.1038/s41467-023-41948-6 · Cited by 233 · see citing works

Machine learning in preclinical drug discovery

Catacutan, D. B., Alexander, J., Arnold, A., & Stokes, J. M. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01679-1 · Cited by 219 · see citing works

Artificial intelligence foundation for therapeutic science

Huang, K., Fu, T., Gao, W., Zhao, Y., Roohani, Y., Leskovec, J., Coley, C. W., Xiao, C., Sun, J., & Zitnik, M. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01131-2 · Cited by 207 · see citing works

Generative AI for designing and validating easily synthesizable and structurally novel antibiotics

Swanson, K., Liu, G., Catacutan, D. B., Arnold, A., Zou, J., & Stokes, J. M. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00809-7 · Cited by 190 · see citing works

Graph networks for molecular design

Mercado, R., Rastemo, T., Lindelöf, E., Klambauer, G., Engkvist, O., Chen, H., & Bjerrum, E. J. (2020) · Machine Learning Science and Technology · doi:10.1088/2632-2153/abcf91 · Cited by 186 · see citing works

Evaluation guidelines for machine learning tools in the chemical sciences

Bender, A., Schneider, N., Segler, M., Walters, W. P., Engkvist, O., & Rodrigues, T. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00391-9 · Cited by 186 · see citing works

Enhancing preclinical drug discovery with artificial intelligence

Vijayan, R., Kihlberg, J. O., Cross, J. B., & Poongavanam, V. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.023 · Cited by 184 · see citing works

Deep learning tools for advancing drug discovery and development

Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 182 · see citing works

Machine‐learning scoring functions for structure‐based virtual screening

Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1478 · Cited by 167 · see citing works

Artificial intelligence in chemistry and drug design

Brown, N., Ertl, P., Lewis, R., Luksch, T., Reker, D., & Schneider, N. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00317-x · Cited by 165 · see citing works

Machine learning and deep learning methods that use omics data for metastasis prediction

Albaradei, S., Thafar, M. A., Alsaedi, A., Neste, C. V., Gojobori, T., Essack, M., & Gao, X. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.09.001 · Cited by 165 · see citing works

Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?

Zhavoronkov, A., Vanhaelen, Q., & Oprea, T. I. (2020) · Clinical Pharmacology &amp; Therapeutics · doi:10.1002/cpt.1795 · Cited by 159 · see citing works

Molecular property prediction: recent trends in the era of artificial intelligence

Shen, J., & Nicolaou, C. A. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2020.05.001 · Cited by 157 · see citing works

Leveraging Uncertainty in Machine Learning Accelerates Biological Discovery and Design

Hie, B., Bryson, B. D., & Berger, B. (2020) · Cell Systems · doi:10.1016/j.cels.2020.09.007 · Cited by 154 · see citing works

The Advent of Generative Chemistry

Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00088 · Cited by 151 · see citing works

AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2

Tang, B., He, F., Liu, D., He, F., Wu, T., Fang, M., Niu, Z., Wu, Z., & Xu, D. H. (2022) · Biomolecules · doi:10.3390/biom12060746 · Cited by 144 · see citing works

AI is a viable alternative to high throughput screening: a 318-target study

Program, T. A. A., Wallach, I., Bernard, D., Nguyen, K. T., Ho, G., Morrison, A., Stecuła, A., Rosnik, A. M., O’Sullivan, A. M., Davtyan, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54655-z · Cited by 137 · see citing works

Generative Artificial Intelligence: Evolving Technology, Growing Societal Impact, and Opportunities for Information Systems Research

Storey, V. C., Yue, W. T., Zhao, J. L., & Lukyanenko, R. (2025) · Information Systems Frontiers · doi:10.1007/s10796-025-10581-7 · Cited by 176 · see citing works

Large language models for reticular chemistry

Zheng, Z., Rampal, N., Inizan, T. J., Borgs, C., Chayes, J. T., & Yaghi, O. M. (2025) · Nature Reviews Materials · doi:10.1038/s41578-025-00772-8 · Cited by 134 · see citing works

New avenues in artificial-intelligence-assisted drug discovery

Cerchia, C., & Lavecchia, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103516 · Cited by 116 · see citing works

Critical assessment of AI in drug discovery

Walters, W. P., & Barzilay, R. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1915982 · Cited by 108 · see citing works

Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections

Talat, A., & Khan, A. U. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103491 · Cited by 96 · see citing works

Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors

Jeon, W., & Kim, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-78537-2 · Cited by 91 · see citing works

Analysis of pharma R&D productivity – a new perspective needed

Schuhmacher, A., Hinder, M., Stein, A. V. S. U., Hartl, D., & Gassmann, O. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103726 · Cited by 88 · see citing works

LLMs and generative agent-based models for complex systems research

Lu, Y., Aleta, A., Du, C., Shi, L., & Moreno, Y. (2024) · Physics of Life Reviews · doi:10.1016/j.plrev.2024.10.013 · Cited by 82 · see citing works

DeepGraphMolGen, a multi-objective, computational strategy for generating molecules with desirable properties: a graph convolution and reinforcement learning approach

Khemchandani, Y., O’Hagan, S., Samanta, S., Swainston, N., Roberts, T. J., Bollegala, D., & Kell, D. B. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00454-3 · Cited by 80 · see citing works

Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study

Thomas, M., Smith, R. T., O’Boyle, N. M., de Graaf, C., & Bender, A. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00516-0 · Cited by 78 · see citing works

Geometry-complete diffusion for 3D molecule generation and optimization

Morehead, A., & Cheng, J. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01233-z · Cited by 81 · see citing works

Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement LearningPreprint

Gottipati, S. K., Sattarov, B., Niu, S., Pathak, Y., Wei, H., Liu, S., Thomas, K. M. J., Blackburn, S., Coley, C. W., Tang, J., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.12485 · Cited by 82 · see citing works

Perceptions and Barriers to Adopting Artificial Intelligence in K-12 Education: A Survey of Educators in Fifty States

Woodruff, K. A., Hutson, J., & Arnone, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002741 · Cited by 76 · see citing works

An invertible, invariant crystal representation for inverse design of solid-state materials using generative deep learning

Xiao, H., Li, R., Shi, X., Chen, Y., Zhu, L., Chen, X., & Wang, L. (2023) · Nature Communications · doi:10.1038/s41467-023-42870-7 · Cited by 72 · see citing works

De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning

Santana, M. V., & Silva, F. P. (2021) · BMC Chemistry · doi:10.1186/s13065-021-00737-2 · Cited by 69 · see citing works

Artificial intelligence in the early stages of drug discovery

Cavasotto, C. N., & Filippo, J. I. D. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108730 · Cited by 67 · see citing works

Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation

Jarallah, S. J., Almughem, F. A., Alhumaid, N. K., Fayez, N. A., Alradwan, I. A., Alsulami, K. A., Tawfik, E. A., & Alshehri, A. A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125789 · Cited by 70 · see citing works

Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases

Guerrero, J. P., Nguewa, P., & García‐Sosa, A. T. (2021) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1513 · Cited by 61 · see citing works

Deep learning and generative methods in cheminformatics and chemical biology: navigating small molecule space intelligently

Kell, D. B., Samanta, S., & Swainston, N. (2020) · Biochemical Journal · doi:10.1042/bcj20200781 · Cited by 56 · see citing works

Recent progress on cheminformatics approaches to epigenetic drug discovery

Sessions, Z. L., Sánchez‐Cruz, N., Prieto-Martínez, F. D., Alves, V. M., Junior, H. P. D. O. S., Muratov, E. N., Tropsha, A., & Medina‐Franco, J. L. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.021 · Cited by 54 · see citing works

Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network

Stecuła, A., Hussain, M. S., & Viola, R. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00473 · Cited by 52 · see citing works

Fake it until you make it? Generative de novo design and virtual screening of synthesizable molecules

Stanley, M., & Segler, M. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102658 · Cited by 48 · see citing works

AI-enhanced chemical paradigm: From molecular graphs to accurate prediction and mechanism

Huang, Z. Z., Jiang, Y. P., He, W., Yu, J., Deng, S., Yang, C., Zhu, W., & Shao, X. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133355 · Cited by 47 · see citing works

AI-driven drug discovery: A boon against COVID-19?

Kaushik, A. C., & Raj, U. (2020) · AI Open · doi:10.1016/j.aiopen.2020.07.001 · Cited by 45 · see citing works

VAE-Sim: A Novel Molecular Similarity Measure Based on a Variational Autoencoder

Samanta, S., O’Hagan, S., Swainston, N., Roberts, T. J., & Kell, D. B. (2020) · Molecules · doi:10.3390/molecules25153446 · Cited by 44 · see citing works

On the Value of Using 3D Shape and Electrostatic Similarities in Deep Generative Methods

Bolcato, G., Heid, E., & Boström, J. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01535 · Cited by 43 · see citing works

Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges

Thomas, M. C., Boardman, A., García-Ortegón, M., Yang, H., de Graaf, C., & Bender, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_1 · Cited by 42 · see citing works

Analyzing behavioral intentions toward Generative Artificial Intelligence: the case of ChatGPT

Nan, D., Sun, S., Zhang, S., Zhao, X., & Kim, J. H. (2024) · Universal Access in the Information Society · doi:10.1007/s10209-024-01116-z · Cited by 40 · see citing works

Molecular set representation learning

Boulougouri, M., Vandergheynst, P., & Probst, D. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00856-0 · Cited by 40 · see citing works

Active Learning Exploration of Transition-Metal Complexes to Discover Method-Insensitive and Synthetically Accessible Chromophores

Duan, C., Nandy, A., Terrones, G., Kastner, D. W., & Kulik, H. J. (2022) · JACS Au · doi:10.1021/jacsau.2c00547 · Cited by 39 · see citing works

Impact of Artificial Intelligence on Compound Discovery, Design, and Synthesis

Miljković, F. N., Rodríguez-Pérez, R., & Bajorath, J. (2021) · ACS Omega · doi:10.1021/acsomega.1c05512 · Cited by 39 · see citing works

Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screening

Kuan, J., Radaeva, M., Avenido, A., Cherkasov, A. R., & Gentile, F. (2023) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1678 · Cited by 43 · see citing works

Drug discovery and development in the era of artificial intelligence: From machine learning to large language models

Guan, S., & Wang, G. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100070 · Cited by 38 · see citing works

MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design

Thomas, M. C., O’Boyle, N. M., Bender, A., & de Graaf, C. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00861-w · Cited by 39 · see citing works

Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases

Müller, C., Rabal, O., & Gonzalez, C. D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_16 · Cited by 37 · see citing works

Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery

Morishita, E. C., & Nakamura, S. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2313455 · Cited by 35 · see citing works

Accelerating discovery of bioactive ligands with pharmacophore-informed generative models

Xie, W., Zhang, J., Xie, Q., Gong, C., Ren, Y., Xie, J. H., Sun, Q., Xu, Y., Lai, L., & Pei, J. (2025) · Nature Communications · doi:10.1038/s41467-025-56349-0 · Cited by 35 · see citing works

Trends in Deep Learning for Property-driven Drug Design

Born, J., & Manica, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210729115728 · Cited by 35 · see citing works

State-of-the-art of Artificial Intelligence in Medicinal Chemistry

Bajorath, J. (2021) · Future Science OA · doi:10.2144/fsoa-2021-0030 · Cited by 33 · see citing works

Artificial Intelligence (AI) in Pharmaceutical Formulation and Dosage Calculations

Joshi, S., & Sheth, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111440 · Cited by 37 · see citing works

Artificial Intelligence and Machine Learning for Lead-to-Candidate Decision-Making and Beyond

McNair, D. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-023255 · Cited by 32 · see citing works

Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries

Bian, Y., & Xie, X. (2022) · Cells · doi:10.3390/cells11050915 · Cited by 32 · see citing works

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

Hu, W., Liu, Y., Chen, X., Chai, W., Chen, H., Wang, H., & Wang, G. (2023) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2023.3251977 · Cited by 30 · see citing works

Graph neural networks driven acceleration in drug discovery

Wang, R., & Zhuang, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.011 · Cited by 33 · see citing works

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence

Moreira‐Filho, J. T., Silva, A. C., Dantas, R. F., Gomes, B. F., Neto, L. R. S., Brandão-Neto, J., Owens, R. J., Furnham, N., Neves, B. J., Silva, F. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642383 · Cited by 31 · see citing works

Revolutionizing Medical Practice: The Impact of Artificial Intelligence (AI) on Healthcare

(2024) · Open Access Journal of Applied Science and Technology · doi:10.33140/oajast.02.01.07 · Cited by 29 · see citing works

Semi-supervised Hierarchical Drug Embedding in Hyperbolic Space

Yu, K., Visweswaran, S., & Batmanghelich, K. N. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00681 · Cited by 28 · see citing works

Deep Learning Applied to Ligand-Based De Novo Drug Design

Palazzesi, F., & Pozzan, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_12 · Cited by 30 · see citing works

Deep Machine Learning for Computer-Aided Drug Design

Bajorath, J. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.829043 · Cited by 27 · see citing works

Cell morphology-guided de novo hit design by conditioning GANs on phenotypic image features

Zapata, P. A. M., Méndez‐Lucio, O., Le, T., Beese, C. J., Wichard, J., Rouquié, D., & Clevert, D.-A. (2022) · Digital Discovery · doi:10.1039/d2dd00081d · Cited by 29 · see citing works

Role of artificial intelligence in chemistry

Choudhary, N., Bharti, R., & Sharma, R. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.09.428 · Cited by 29 · see citing works

Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence

Maria, J. P. S., Wang, Y., & Camargo, L. M. (2023) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2023.1121591 · Cited by 29 · see citing works

Artifical intelligence: a virtual chemist for natural product drug discovery

Arora, S., Chettri, S., Percha, V., Kumar, D., & Latwal, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2216295 · Cited by 25 · see citing works

Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design

Thomas, M. C., Matricon, P. G., Gillespie, R. F., Napiórkowska, M., Neale, H., Mason, J. S., Brown, J., Harwood, K., Fieldhouse, C., Swain, N. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60629-0 · Cited by 25 · see citing works

Generative AI for the Design of Molecules: Advances and Challenges

Sun, Y., Chen, L., Jing, Z., Li, Y. Y., Kim, D., Gao, J.-Y., Noroozi, R., Yi, G. Y., Feugmo, C. G. T., Klinkova, A., et al. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02234 · Cited by 27 · see citing works

Data-Driven Cheminformatics Models for Predicting Bioactivity of Natural Compounds in Oncology

Atalor, S. I. (2022) · International Journal of Scientific Research and Modern Technology. · doi:10.38124/ijsrmt.v1i1.496 · Cited by 24 · see citing works

Reply to ‘Assessing the impact of generative AI on medicinal chemistry’

Zhavoronkov, A. A., & Aspuru‐Guzik, A. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0417-3 · Cited by 24 · see citing works

Hit and Lead Discovery with Explorative RL and Fragment-based Molecule GenerationPreprint

Yang, S., Hwang, D., Lee, S., Ryu, S., & Hwang, S. J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2110.01219 · Cited by 24 · see citing works

Artificial Intelligence in Toxicology and Pharmacology

Nasnodkar, S. P., Çınar, B., & Ness, S. (2023) · Journal of Engineering Research and Reports · doi:10.9734/jerr/2023/v25i7952 · Cited by 24 · see citing works

Latent Variable Machine Learning Framework for Catalysis: General Models, Transfer Learning, and Interpretability

Kayode, G. O., & Montemore, M. M. (2023) · JACS Au · doi:10.1021/jacsau.3c00419 · Cited by 23 · see citing works

Ontology in Hybrid Intelligence: A Concise Literature Review

Pileggi, S. F. (2024) · Future Internet · doi:10.3390/fi16080268 · Cited by 28 · see citing works

On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach

Lim, S., Lee, S., Piao, Y., Choi, M., Bang, D., Gu, J., & Kim, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.049 · Cited by 23 · see citing works

Leveraging generative models with periodicity-aware, invertible and invariant representations for crystalline materials design

Wang, Z., & You, F. (2025) · Nature Computational Science · doi:10.1038/s43588-025-00797-7 · Cited by 21 · see citing works

Automated Generation of Novel Fragments Using Screening Data, a Dual SMILES Autoencoder, Transfer Learning and Syntax Correction

Bilsland, A. E., McAulay, K., West, R., Pugliese, A., & Bower, J. F. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01226 · Cited by 21 · see citing works

High-resolution protein modeling through Cryo-EM and AI: current trends and future perspectives – a review

Jeyaraj, G., Rajendran, A. K., Sathishkumar, K., Almutairi, B. O., Vadivelu, A., Chokkakula, S., Tu, Y., & Xie, W. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1688455 · Cited by 23 · see citing works

Recent omics-based computational methods for COVID-19 drug discovery and repurposing

Tayara, H., Abdelbaky, I., & Chong, K. T. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab339 · Cited by 20 · see citing works

Recent progress towards a universal machine learning model for reaction energetics in heterogeneous catalysis

Sulley, G. A., & Montemore, M. M. (2022) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2022.100821 · Cited by 21 · see citing works

Improving de novo Molecule Generation by Embedding LSTM and Attention Mechanism in CycleGAN

Wang, F., Feng, X., Guo, X., Xu, L., Xie, L., & Chang, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.709500 · Cited by 20 · see citing works

Reply to ‘Assessing the impact of generative AI on medicinal chemistry’

Zhavoronkov, A. A., & Aspuru‐Guzik, A. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0417-3 · Cited by 24 · see citing works

Generative AI Models for Drug Discovery

Tang, B., Ewalt, J., & Ng, H. L. (2021) · Topics in medicinal chemistry · doi:10.1007/7355_2021_124 · Cited by 37 · see citing works

Modern hit-finding with structure-guided de novo design: identification of novel nanomolar adenosine A2A receptor ligands using reinforcement learningPreprint

Thomas, M. C., Matricon, P. G., Gillespie, R. F., Napiórkowska, M., Neale, H., Mason, J. S., Brown, J., Fieldhouse, C., Swain, N. A., Geng, T., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-wh7zw-v2 · Cited by 1 · see citing works

Generative Artificial Intelligence in Pharmaceutical Research and Drug Discovery

Sayed, M. A. (2024) · doi:10.13140/rg.2.2.28297.66402

Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design

Thomas, M. C., Matricon, P. G., Gillespie, R. F., Napiórkowska, M., Neale, H., Mason, J. S., Brown, J., Harwood, K., Fieldhouse, C., Swain, N. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60629-0 · Cited by 25 · see citing works